Nifty
Sensex
:
:
17843.15
60614.72
121.65 (0.69%)
328.68 (0.55%)

Pharmaceuticals & Drugs - Veterinary

Rating :
28/99

BSE: 512529 | NSE: SEQUENT

73.60
08-Feb-2023
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 72.05
  • 74.20
  • 70.75
  • 71.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  932132
  •  673.09
  •  162.75
  •  70.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,838.32
  • 216.55
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,093.96
  • N/A
  • 2.43

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.79%
  • 6.85%
  • 28.60%
  • FII
  • DII
  • Others
  • 6.25%
  • 1.46%
  • 4.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.76
  • 6.51
  • 6.21

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.05
  • -0.38
  • -8.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -37.18
  • -16.13

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.24
  • 49.67
  • 62.00

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.57
  • 4.10
  • 5.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 41.60
  • 21.04
  • 24.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
337.61
350.55
-3.69%
341.32
320.51
6.49%
383.71
361.82
6.05%
358.05
355.06
0.84%
Expenses
334.74
330.87
1.17%
339.21
300.35
12.94%
350.36
318.54
9.99%
321.83
290.54
10.77%
EBITDA
2.87
19.68
-85.42%
2.12
20.16
-89.48%
33.35
43.28
-22.94%
36.22
64.52
-43.86%
EBIDTM
0.85%
5.61%
0.62%
6.29%
8.69%
11.96%
10.12%
18.17%
Other Income
0.91
0.74
22.97%
0.88
2.67
-67.04%
3.77
1.37
175.18%
3.67
2.81
30.60%
Interest
8.12
3.26
149.08%
6.80
3.02
125.17%
6.04
3.18
89.94%
3.45
6.20
-44.35%
Depreciation
13.38
13.21
1.29%
12.56
12.57
-0.08%
12.47
12.68
-1.66%
12.83
11.58
10.79%
PBT
-17.72
3.95
-
-19.57
7.23
-
18.61
29.01
-35.85%
23.61
49.55
-52.35%
Tax
-13.28
-9.88
-
-5.16
4.58
-
8.57
5.49
56.10%
5.05
11.57
-56.35%
PAT
-4.44
13.82
-
-14.41
2.65
-
10.04
23.52
-57.31%
18.56
37.98
-51.13%
PATM
-1.32%
3.94%
-4.22%
0.83%
2.62%
6.50%
5.18%
10.70%
EPS
-0.15
0.58
-
-0.56
0.04
-
0.36
0.83
-56.63%
0.69
1.43
-51.75%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
1,420.69
1,412.82
1,361.62
1,179.24
1,039.31
1,030.59
683.57
624.98
465.36
455.46
326.86
Net Sales Growth
2.36%
3.76%
15.47%
13.46%
0.85%
50.77%
9.37%
34.30%
2.17%
39.34%
 
Cost Of Goods Sold
820.91
792.99
694.65
605.05
543.01
554.23
356.70
311.71
240.72
243.65
181.72
Gross Profit
599.78
619.82
666.96
574.19
496.30
476.36
326.87
313.27
224.65
211.81
145.14
GP Margin
42.22%
43.87%
48.98%
48.69%
47.75%
46.22%
47.82%
50.12%
48.27%
46.50%
44.40%
Total Expenditure
1,346.14
1,303.43
1,151.68
1,008.92
914.37
919.10
643.03
568.27
444.87
438.68
342.51
Power & Fuel Cost
-
33.86
28.75
24.73
23.06
14.66
12.77
26.51
23.32
22.06
23.53
% Of Sales
-
2.40%
2.11%
2.10%
2.22%
1.42%
1.87%
4.24%
5.01%
4.84%
7.20%
Employee Cost
-
231.37
187.22
165.06
145.95
132.07
106.22
88.62
62.39
48.12
41.47
% Of Sales
-
16.38%
13.75%
14.00%
14.04%
12.81%
15.54%
14.18%
13.41%
10.57%
12.69%
Manufacturing Exp.
-
93.67
96.18
83.24
77.73
59.07
57.63
72.14
54.31
52.30
41.42
% Of Sales
-
6.63%
7.06%
7.06%
7.48%
5.73%
8.43%
11.54%
11.67%
11.48%
12.67%
General & Admin Exp.
-
66.90
58.40
56.37
58.35
70.92
48.60
36.44
33.79
43.58
23.96
% Of Sales
-
4.74%
4.29%
4.78%
5.61%
6.88%
7.11%
5.83%
7.26%
9.57%
7.33%
Selling & Distn. Exp.
-
57.11
50.00
45.16
36.29
36.87
28.78
17.46
20.27
12.30
10.51
% Of Sales
-
4.04%
3.67%
3.83%
3.49%
3.58%
4.21%
2.79%
4.36%
2.70%
3.22%
Miscellaneous Exp.
-
27.52
36.47
29.32
29.98
51.29
32.34
15.40
10.07
16.66
10.51
% Of Sales
-
1.95%
2.68%
2.49%
2.88%
4.98%
4.73%
2.46%
2.16%
3.66%
6.09%
EBITDA
74.56
109.39
209.94
170.32
124.94
111.49
40.54
56.71
20.49
16.78
-15.65
EBITDA Margin
5.25%
7.74%
15.42%
14.44%
12.02%
10.82%
5.93%
9.07%
4.40%
3.68%
-4.79%
Other Income
9.23
10.86
10.49
10.09
8.67
17.20
11.08
14.30
9.96
3.84
4.96
Interest
24.41
15.77
24.38
35.71
32.80
39.70
28.34
38.56
44.37
39.04
33.45
Depreciation
51.24
51.09
50.60
50.62
41.92
53.30
40.07
46.22
32.94
32.60
28.61
PBT
4.93
53.39
145.45
94.08
58.88
35.70
-16.80
-13.77
-46.85
-51.00
-72.75
Tax
-4.82
8.33
32.18
12.03
2.01
13.46
-0.41
2.62
3.39
0.58
-8.06
Tax Rate
-97.77%
15.60%
23.55%
12.79%
3.41%
3.03%
2.44%
-19.03%
-40.50%
-0.53%
11.08%
PAT
9.75
41.25
95.44
69.91
48.66
421.57
-13.83
-18.47
-10.74
-110.49
-64.69
PAT before Minority Interest
8.28
45.06
104.45
82.05
56.88
430.83
-16.39
-16.39
-11.76
-110.49
-64.69
Minority Interest
-1.47
-3.81
-9.01
-12.14
-8.22
-9.26
2.56
-2.08
1.02
0.00
0.00
PAT Margin
0.69%
2.92%
7.01%
5.93%
4.68%
40.91%
-2.02%
-2.96%
-2.31%
-24.26%
-19.79%
PAT Growth
-87.50%
-56.78%
36.52%
43.67%
-88.46%
-
-
-
-
-
 
EPS
0.39
1.65
3.83
2.80
1.95
16.90
-0.55
-0.74
-0.43
-4.43
-2.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
692.41
727.65
687.10
706.69
647.58
976.79
945.71
91.27
56.73
95.00
Share Capital
49.67
49.67
49.67
49.37
48.75
48.75
47.65
30.48
26.74
23.44
Total Reserves
595.64
670.21
623.34
638.43
581.25
912.49
874.01
26.85
-0.37
59.68
Non-Current Liabilities
199.33
153.58
216.46
214.75
227.13
246.20
299.72
277.55
159.23
144.35
Secured Loans
87.25
62.52
108.88
126.94
85.14
141.76
197.50
249.97
150.52
137.32
Unsecured Loans
35.21
31.18
41.18
20.90
18.40
23.38
13.82
0.35
0.56
0.72
Long Term Provisions
55.95
27.19
13.16
30.50
28.54
34.76
28.66
25.70
8.03
6.09
Current Liabilities
537.35
513.11
514.86
440.41
430.93
663.55
290.37
406.09
405.28
345.41
Trade Payables
258.05
226.91
220.38
209.35
160.49
203.04
143.94
90.94
114.59
150.91
Other Current Liabilities
78.99
100.64
104.98
87.80
106.52
259.26
83.23
107.43
56.80
35.63
Short Term Borrowings
159.54
102.91
147.12
127.36
152.41
194.70
56.04
204.31
226.60
151.76
Short Term Provisions
40.77
82.66
42.38
15.90
11.51
6.54
7.17
3.42
7.29
7.12
Total Liabilities
1,477.10
1,443.00
1,463.16
1,402.10
1,342.62
1,903.76
1,538.02
921.84
625.82
589.34
Net Block
554.97
535.66
576.57
498.14
475.97
684.33
586.48
474.43
237.59
227.26
Gross Block
816.26
753.25
762.46
638.06
581.74
789.60
643.70
596.25
369.07
330.69
Accumulated Depreciation
261.29
217.60
185.89
139.91
105.77
105.27
57.22
121.82
131.48
103.43
Non Current Assets
665.16
676.33
738.86
795.99
804.61
1,176.02
1,047.48
612.00
359.87
358.31
Capital Work in Progress
11.63
30.79
13.42
22.61
18.04
32.55
23.52
39.06
43.04
88.71
Non Current Investment
36.79
76.94
131.29
179.65
221.73
363.97
360.58
58.04
0.04
1.64
Long Term Loans & Adv.
53.92
32.15
14.40
32.27
31.01
37.51
30.35
36.01
76.06
39.28
Other Non Current Assets
7.85
0.79
3.18
63.31
57.86
57.66
46.54
4.47
3.15
1.42
Current Assets
811.93
766.68
724.30
606.12
538.01
727.74
490.54
309.84
265.94
231.04
Current Investments
1.44
5.66
40.18
0.47
17.34
64.12
66.98
0.58
0.08
0.18
Inventories
347.97
264.36
219.42
200.10
158.57
160.81
135.08
94.36
101.40
85.62
Sundry Debtors
329.24
346.14
318.76
278.25
258.35
254.62
192.39
115.44
83.54
65.81
Cash & Bank
59.25
56.20
75.83
72.04
42.45
47.40
25.30
38.46
36.21
33.00
Other Current Assets
74.03
16.82
14.79
8.51
61.30
200.79
70.80
61.01
44.71
46.44
Short Term Loans & Adv.
66.35
77.52
55.33
46.75
56.05
54.48
46.69
41.86
37.47
36.48
Net Current Assets
274.58
253.57
209.44
165.71
107.08
64.19
200.17
-96.25
-139.34
-114.37
Total Assets
1,477.09
1,443.01
1,463.16
1,402.11
1,342.62
1,903.76
1,538.02
921.84
625.81
589.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
30.59
114.75
115.33
116.02
45.24
-7.19
-0.05
-23.55
-44.78
-3.82
PBT
53.39
145.45
94.08
58.88
445.79
-16.80
-13.77
-8.37
-109.91
-72.75
Adjustment
93.27
83.98
91.41
84.47
-313.85
123.31
83.81
35.92
133.52
65.98
Changes in Working Capital
-89.30
-70.89
-58.30
-27.95
-77.87
-104.37
-71.46
-53.98
-67.45
2.48
Cash after chg. in Working capital
57.36
158.55
127.18
115.40
54.06
2.14
-1.42
-26.44
-43.84
-4.28
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-26.77
-43.79
-11.85
0.62
-8.83
-9.33
1.37
2.89
-0.95
0.46
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-95.57
9.65
-72.27
-67.69
7.17
-116.18
-315.83
-154.69
-79.95
-54.89
Net Fixed Assets
-7.29
-4.18
-29.66
-32.63
221.87
-49.63
97.97
38.51
-26.62
-28.82
Net Investments
26.57
72.52
30.56
-101.61
210.25
0.26
-713.97
-118.07
-10.37
-15.66
Others
-114.85
-58.69
-73.17
66.55
-424.95
-66.81
300.17
-75.13
-42.96
-10.41
Cash from Financing Activity
67.26
-138.75
-42.75
-20.08
-56.96
147.44
308.69
179.41
145.54
34.70
Net Cash Inflow / Outflow
2.29
-14.35
0.31
28.25
-4.55
24.07
-7.19
1.17
20.80
-24.02
Opening Cash & Equivalents
53.74
68.10
67.79
39.54
44.10
20.03
21.85
22.96
3.45
27.37
Closing Cash & Equivalent
57.50
53.74
68.10
67.79
39.54
44.10
20.03
21.83
22.96
3.45

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
25.98
28.98
27.10
27.86
25.85
39.44
38.69
3.76
1.97
7.09
ROA
3.09%
7.19%
5.73%
4.14%
26.54%
-0.95%
-1.33%
-1.52%
-18.19%
-11.23%
ROE
6.60%
15.00%
12.06%
8.63%
54.15%
-1.74%
-3.35%
-28.10%
-201.83%
-62.91%
ROCE
7.06%
16.24%
12.59%
9.24%
41.28%
0.87%
2.72%
6.93%
-16.09%
-9.86%
Fixed Asset Turnover
1.80
1.80
1.72
1.74
1.51
0.96
1.03
1.01
1.36
1.08
Receivable days
87.24
89.12
90.45
92.53
90.49
118.40
87.75
74.80
57.30
72.70
Inventory Days
79.10
64.84
63.56
61.85
56.34
78.37
65.41
73.58
71.75
82.12
Payable days
111.61
117.51
80.72
75.36
77.04
104.11
77.28
87.31
115.68
149.32
Cash Conversion Cycle
54.73
36.45
73.29
79.02
69.78
92.66
75.87
61.07
13.36
5.51
Total Debt/Equity
0.49
0.31
0.51
0.47
0.48
0.43
0.34
8.26
15.86
3.74
Interest Cover
4.38
6.60
3.63
2.80
12.19
0.41
0.64
0.81
-1.82
-1.18

News Update:


  • Sequent Scientific gets nod to acquire 100% stake in Tineta Pharma
    8th Nov 2022, 12:58 PM

    The Board of Directors of the Company at their meeting held on November 7, 2022, has considered and approved the same

    Read More
  • Sequent Scientific - Quarterly Results
    7th Nov 2022, 20:36 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.